These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 33427358)
21. Incidence of human papillomavirus-related oropharyngeal cancer and outcomes after chemoradiation in a population of heavy smokers. Cerezo L; López C; de la Torre A; Suárez D; Hervás A; Ruiz A; Ballestín C; Martín M; Sandoval P Head Neck; 2014 Jun; 36(6):782-6. PubMed ID: 23616290 [TBL] [Abstract][Full Text] [Related]
22. Evaluating the impact of smoking on disease-specific survival outcomes in patients with human papillomavirus-associated oropharyngeal cancer treated with transoral robotic surgery. Roden DF; Hobelmann K; Vimawala S; Richa T; Fundakowski CE; Goldman R; Luginbuhl A; Curry JM; Cognetti DM Cancer; 2020 Jan; 126(9):1873-1887. PubMed ID: 32032441 [TBL] [Abstract][Full Text] [Related]
23. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma. Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504 [TBL] [Abstract][Full Text] [Related]
24. Radiographic retropharyngeal lymph node involvement in HPV-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomes. Lin TA; Garden AS; Elhalawani H; Elgohari B; Jethanandani A; Ng SP; Mohamed AS; Frank SJ; Glisson BS; Debnam JM; Sturgis EM; Phan J; Reddy JP; Fuller CD; Morrison WH; Skinner HD; Rosenthal DI; Gunn GB Cancer; 2019 May; 125(9):1536-1546. PubMed ID: 30620385 [TBL] [Abstract][Full Text] [Related]
25. Influence of HPV-status on survival of patients with tonsillar carcinomas (TSCC) treated by CO Hoffmann M; Quabius ES; Tribius S; Gebhardt S; Görögh T; Hedderich J; Huber K; Dunst J; Ambrosch P Cancer Lett; 2018 Jan; 413():59-68. PubMed ID: 29100961 [TBL] [Abstract][Full Text] [Related]
26. Cancer of the Oropharynx and the Association with Human Papillomavirus. Rettig EM; Sethi RKV Hematol Oncol Clin North Am; 2021 Oct; 35(5):913-931. PubMed ID: 34244016 [TBL] [Abstract][Full Text] [Related]
27. Impact of human papillomavirus on outcome in patients with oropharyngeal cancer treated with primary surgery. Broglie MA; Stoeckli SJ; Sauter R; Pasche P; Reinhard A; de Leval L; Huber GF; Pezier TF; Soltermann A; Giger R; Arnold A; Dettmer M; Arnoux A; Müller M; Spreitzer S; Lang F; Lutchmaya M; Stauffer E; Espeli V; Martucci F; Bongiovanni M; Foerbs D; Jochum W Head Neck; 2017 Oct; 39(10):2004-2015. PubMed ID: 28691255 [TBL] [Abstract][Full Text] [Related]
28. Impact of human papillomavirus status on survival and recurrence in a geographic region with a low prevalence of HPV-related cancer: A retrospective cohort study. De Cicco R; de Melo Menezes R; Nicolau UR; Pinto CAL; Villa LL; Kowalski LP Head Neck; 2020 Jan; 42(1):93-102. PubMed ID: 31633252 [TBL] [Abstract][Full Text] [Related]
29. De-intensification of therapy in human papillomavirus associated oropharyngeal cancer: A systematic review of prospective trials. Patel RR; Ludmir EB; Augustyn A; Zaorsky NG; Lehrer EJ; Ryali R; Trifiletti DM; Adeberg S; Amini A; Verma V Oral Oncol; 2020 Apr; 103():104608. PubMed ID: 32163853 [TBL] [Abstract][Full Text] [Related]
30. The prognostic role of medical comorbidities in surgically treated human papillomavirus-associated oropharyngeal squamous cell carcinoma. Yin LX; Puccinelli CL; Price DL; Karp EE; Price KA; Ma DJ; Lohse C; Moore EJ; Abel KMV Oral Oncol; 2020 Sep; 108():104822. PubMed ID: 32504888 [TBL] [Abstract][Full Text] [Related]
31. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma. An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338 [TBL] [Abstract][Full Text] [Related]
32. Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study. Granata R; Miceli R; Orlandi E; Perrone F; Cortelazzi B; Franceschini M; Locati LD; Bossi P; Bergamini C; Mirabile A; Mariani L; Olmi P; Scaramellini G; Potepan P; Quattrone P; Ang KK; Licitra L Ann Oncol; 2012 Jul; 23(7):1832-7. PubMed ID: 22115925 [TBL] [Abstract][Full Text] [Related]
33. Development and Assessment of a Novel Composite Pathologic Risk Stratification for Surgically Resected Human Papillomavirus-Associated Oropharyngeal Cancer. Cramer JD; Dundar Y; Hotaling J; Raza SN; Lin HS JAMA Otolaryngol Head Neck Surg; 2019 Dec; 145(12):1105-1114. PubMed ID: 31042786 [TBL] [Abstract][Full Text] [Related]
34. Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status. Huang SH; Waldron JN; Milosevic M; Shen X; Ringash J; Su J; Tong L; Perez-Ordonez B; Weinreb I; Bayley AJ; Kim J; Hope A; Cho BC; Giuliani M; Razak A; Goldstein D; Shi W; Liu FF; Xu W; O'Sullivan B Cancer; 2015 Feb; 121(4):545-55. PubMed ID: 25336438 [TBL] [Abstract][Full Text] [Related]
35. Treatment de-escalation for HPV+ oropharyngeal cancer: A systematic review and meta-analysis. Petrelli F; Luciani A; Ghidini A; Cherri S; Gamba P; Maddalo M; Bossi P; Zaniboni A Head Neck; 2022 May; 44(5):1255-1266. PubMed ID: 35238114 [TBL] [Abstract][Full Text] [Related]
36. Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial. Nichols AC; Lang P; Prisman E; Berthelet E; Tran E; Hamilton S; Wu J; Fung K; de Almeida JR; Bayley A; Goldstein DP; Eskander A; Husain Z; Bahig H; Christopoulous A; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Mendez A; Winquist E; Read N; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Corsten M; Rajaraman M; Johnson-Obaseki S; Eapen L; Odell M; Chandarana S; Banerjee R; Dort J; Matthews TW; Hart R; Kerr P; Dowthwaite S; Gupta M; Zhang H; Wright J; Parker C; Wehrli B; Kwan K; Theurer J; Palma DA BMC Cancer; 2020 Feb; 20(1):125. PubMed ID: 32059705 [TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma. Ang KK; Sturgis EM Semin Radiat Oncol; 2012 Apr; 22(2):128-42. PubMed ID: 22385920 [TBL] [Abstract][Full Text] [Related]
38. Oropharyngeal cancer prognosis by tumour HPV status in France: The multicentric Papillophar study. Lacau St Guily J; Rousseau A; Baujat B; Périé S; Schultz P; Barry B; Dufour X; Malard O; Pretet JL; Clavel C; Birembaut P; Franceschi S; Oral Oncol; 2017 Apr; 67():29-36. PubMed ID: 28351578 [TBL] [Abstract][Full Text] [Related]
39. Impact of chemotherapy regimen on treatment outcomes in patients with HPV-associated oropharyngeal cancer with T4 disease treated with definitive concurrent chemoradiation. Bhattasali O; Ryoo JJ; Thompson LDR; Abdalla IA; Chen J; Iganej S Oral Oncol; 2019 Aug; 95():74-78. PubMed ID: 31345397 [TBL] [Abstract][Full Text] [Related]
40. The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre. Habbous S; Chu KP; Qiu X; La Delfa A; Harland LT; Fadhel E; Hui A; Perez-Ordonez B; Weinreb I; Liu FF; Waldron J; O'Sullivan B; Goldstein D; Xu W; Huang SH; Liu G Cancer Epidemiol; 2013 Dec; 37(6):820-9. PubMed ID: 24184275 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]